Mark T. Fleming
Impact in
-
- Occupational Health and Safety Research
- Pulmonary and Respiratory Medicine top 0.2%
- Prostate Cancer Treatment and Research
- Prostate Cancer Diagnosis and Treatment
Papers in
-
- Prostate Cancer Treatment and Research 41
- Oncology 36
- Cancer Immunotherapy and Biomarkers 19
- Cancer Treatment and Pharmacology 14
- Co-authors
- Howard I. Scher (9 shared papers)Johann S. de Bono (10 shared papers)Fred Saad (3 shared papers)Karim Fizazi (6 shared papers)Neal D. Shore (13 shared papers)Andrew J. Armstrong (5 shared papers)Kim N. (4 shared papers)Mary‐Ellen Taplin (3 shared papers)
- Journals
- Journal of Clinical Oncology (43 papers)Annals of Oncology (8 papers)Sexually Transmitted Diseases (5 papers)The Journal of Urology (4 papers)Clinical Cancer Research (4 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Mark T. Fleming
131 papers receiving 6.3k citations
Mark T. Fleming's Hit Papers
Peers
Comparison fields: 5 of 150
- Radiological and Ultrasound Technology 692
- Pulmonary and Respiratory Medicine 3.5k
- Medical Laboratory Technology 152
- Statistics, Probability and Uncertainty 526
- Cancer Research 846
Countries citing papers authored by Mark T. Fleming
This map shows the geographic impact of Mark T. Fleming's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark T. Fleming with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark T. Fleming more than expected).
Fields of papers citing papers by Mark T. Fleming
This network shows the impact of papers produced by Mark T. Fleming. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark T. Fleming. The network helps show where Mark T. Fleming may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark T. Fleming, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 131 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Increased Survival with Enzalutamide in Prostate Cancer after Chemotherapy Hit paper breakdown → | 2012 | 3428 |
| 2 | 1998 | 245 | |
| 3 | Talazoparib monotherapy in metastatic castration-resistant prostate cancer with DNA repair alterations (TALAPRO-1): an open-label, phase 2 trial Hit paper breakdown → | 2021 | 192 |
| 4 | 2001 | 170 | |
| 5 | 2012 | 150 | |
| 6 | 2011 | 123 | |
| 7 | 2009 | 115 | |
| 8 | 1996 | 68 | |
| 9 | 2011 | 67 | |
| 10 | 2005 | 63 | |
| 11 | 2006 | 62 | |
| 12 | 2008 | 62 | |
| 13 | 2008 | 60 | |
| 14 | 2019 | 60 | |
| 15 | 2004 | 58 | |
| 16 | 2013 | 57 | |
| 17 | 2010 | 55 | |
| 18 | 2018 | 55 | |
| 19 | 2009 | 54 | |
| 20 | 2009 | 53 |
About Mark T. Fleming
Mark T. Fleming is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Radiology, Nuclear Medicine and Imaging and Radiological and Ultrasound Technology, having authored 131 papers that have together received 6.5k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (41 papers), Bladder and Urothelial Cancer Treatments (30 papers), Radiopharmaceutical Chemistry and Applications (22 papers), Cancer Immunotherapy and Biomarkers (19 papers), Occupational Health and Safety Research (19 papers), Risk and Safety Analysis (15 papers), Cancer Treatment and Pharmacology (14 papers) and Urinary and Genital Oncology Studies (13 papers). The work is most often cited by research in Radiological and Ultrasound Technology (692 citations), Pulmonary and Respiratory Medicine (3.5k citations), Medical Laboratory Technology (152 citations), Statistics, Probability and Uncertainty (526 citations) and Cancer Research (846 citations). Mark T. Fleming has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Howard I. Scher, Johann S. de Bono, Fred Saad, Karim Fizazi, Neal D. Shore, Andrew J. Armstrong, Kim N., Mary‐Ellen Taplin, Cora N. Sternberg and Mohammad Hirmand. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Sexually Transmitted Diseases, The Journal of Urology and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.